Additionally, in this study, over half of thyroid nodules were classified in category I (undiagnosed) and II (benign) and the BRAF V600E mutation rates were 12% and 4%, respectively, with similar malignancy rates reported in previous studies.21 Here, BRAF is linked to thyroid nodule.